Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude's $167 Mil. Angio-Seal Puncture Closure Buy Adds $50 Mil. In Sales

This article was originally published in The Gray Sheet

Executive Summary

St. Jude's $167 mil. cash acquisition of marketing and manufacturing rights to Kensey Nash's Angio-Seal hemostatic puncture closure device from Tyco International would "more than double" sales into the cardiology cath lab by St. Jude's Daig division and add 60 to its sales and marketing staff, the firm states.

You may also be interested in...



Expanded AngioSeal Supply Deal Heightens Investor Interest In Kensey Nash

Kensey Nash's ability to convince investors that AngioSeal will generate sales exceeding $75 mil. over the life of a multi-year contract with St. Jude Medical helped the supplier's stock price swell by more than 11% during June

Expanded AngioSeal Supply Deal Heightens Investor Interest In Kensey Nash

Kensey Nash's ability to convince investors that AngioSeal will generate sales exceeding $75 mil. over the life of a multi-year contract with St. Jude Medical helped the supplier's stock price swell by more than 11% during June

Kensey Nash Extracts Biomaterials Growth To Curb Reliance On Angio-Seal

Kensey Nash likely will pursue an acquisition strategy and an expanded client base to leverage its biomaterial patents and manufacturing capability

Related Content

UsernamePublicRestriction

Register

MT011306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel